Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis (ALS), also known as Charcot’s disease in France or Lou Gehrig’s disease in the United States, is a serious, disabling neurodegenerative disease, which is genetic in 10% of sufferers [1]. With a prevalence of around 6 cases per 100,000 people, it is the most common of the so-called motor neurone diseases [2],[3]. It leads to progressive paralysis of the muscles involved in voluntary motricity, including the respiratory muscles [4].


[1] https://www.inserm.fr/dossier/sclerose-laterale-amyotrophique-sla-maladie-charcot/

[2] https://pubmed.ncbi.nlm.nih.gov/27637961

[3] https://www.arsla.org/la-sla-cest-quoi/

[4] https://www.inserm.fr/dossier/sclerose-laterale-amyotrophique-sla-maladie-charcot/